An interventional study of propofol ( Paedfusor Model) and propofol (Eleveld Model) in Emergence Delirium in Pediatric Anesthesia, Pediatric Anesthesia and Postoperative Agitations in Pediatric Patients, sponsored by Marmara University Pendik Training and Research Hospital. Recruiting at 2 sites in Turkey (Türkiye). Open to participants aged 3 Years to 10 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-16.
Sponsored by Marmara University Pendik Training and Research Hospital · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 96 studies in Postoperative Nausea and Vomiting with a site in Turkey — 22 open to participants now, 23 under way, none of them phase 3. Postoperative Nausea and Vomiting · Turkey.
Among the 96 studies in Postoperative Nausea and Vomiting with a site in Turkey, this one is the 13th largest by planned enrollment of the 71 interventional ones that give a count, is one of 12 that started in 2026, is one of 55 with no phase, reaches primary completion later than 22 of the 22 other live ones, and was the 87th registered.
638 studies on the registry are indexed under Postoperative Nausea and Vomiting; 110 are open to participants now.
Browse Postoperative Nausea and Vomiting studies →22 of the 96 studies in Postoperative Nausea and Vomiting with a site in Turkey are open now. Recruiting first, the newest first:
Filiz Kaya · Sites in Turkey
Ages 18–65
Konya City Hospital · Sites in Turkey
Ages 18–45 · Women only
Ankara Etlik City Hospital · Sites in Turkey
Ages 18–65 · Women only
Nigde Omer Halisdemir University · Sites in Turkey
Ages 18–45 · Women only
Trabzon Kanuni Education and Research Hospital · Sites in Turkey
Ages 18–65 · Healthy volunteers
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 66 Postoperative Nausea and Vomiting studies recruiting now, 22 (33%) set no upper age limit and 38 (58%) stop at 75 or younger; 15 take children under 18; 11 take healthy volunteers.
This study: 3 Years to 10 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
96 studies; the count open now beside each. This study's row is marked.
First in 2004; this study’s year is marked. 12 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 150 is above the median of 112 across 529 interventional studies indexed under Postoperative Nausea and Vomiting.
Median enrollment 90 across the 71 interventional studies, 100 across the 25 observational. Of the 61 that completed or were terminated, 3 (5%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 96 have an industry lead sponsor. The 10 most frequent:
Marmara University Pendik Training and Research Hospital is the lead sponsor of 35 studies on the registry; 16 are open to participants now.
Marmara University Pendik Training and Research Hospital has 1 study filed under Postoperative Nausea and Vomiting — fewer than ten, so there is no comparison to draw.
8 of the studies in Postoperative Nausea and Vomiting with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07440667Nigde Omer Halisdemir UniversityRestrictive vs Liberal Intraoperative Fluid Strategy and Postoperative Outcomes After Elective Cesarean Section | 2027-01-30 |
| NCT07539831Konya City HospitalEffects of Menstrual Cycle on Optic Nerve Sheath Diameter in Patients Undergoing Laparoscopic Gynecologic Surgery | 2027-03-03 |
| NCT07858058Ataturk UniversityThe Effect of White and Pink Noise in Patients Undergoing Total Hip and Knee Arthroplasty | 2027-03-15 |
| NCT07916077Ankara Etlik City HospitalPreoperative Gastric Volume and PONV in Pediatric Appendectomy Cases | 2027-04-15 |
| NCT07879274Bitlis Eren UniversityBinaural Beats and Postoperative Nausea and Vomiting in Laparoscopic Cholecystectomy | 2027-04-30 |
Add all 8 to your calendar (.ics) → With an account.
Among the 96 studies in Postoperative Nausea and Vomiting with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Emergence delirium is a common complication in pediatric patients undergoing general anesthesia. The aim of this study is to investigate the incidence of postoperative awakening delirium and agitation in pediatric patients aged 3-10 years (ASA I-II) using two different target-controlled infusion (TCI) methods (Paedfusor and Eleveld) for TIVA, compared to inhalation anesthesia. This study will examine the effect of two different TCI models on postoperative awakening agitation/delirium by comparing them with each other and with inhalation anesthesia.
Postoperative emergence agitation/delirium (POED) is a postoperative complication in pediatric anesthesia and is characterized by perceptual and psychomotor impairment that negatively impacts postoperative recovery. According to the literature, inhalation anesthesia is associated with a higher incidence of ED compared to propofol-based anesthesia. In this study, we aimed to investigate the effect of two different TCI models, in which the depth of general anesthesia was monitored with BIS monitoring, on reducing the incidence of ED.
Both the Paedfusor and Eleveld models describe propofol pharmacokinetics via a three-compartment structure. These pharmacokinetic models are drug infusion models created by taking 600-10,000 blood samples at specific intervals after administering various doses of the drug to real patients and measuring the blood concentrations. They are used to provide a more stable and consistent level of total intravenous anesthesia.
Both models have been used for propofol infusion in pediatric anesthesia for many years. Differences exist between them in terms of distribution volume, elimination rate constant between compartments, and induction and maintenance phases depending on the characteristics of the pharmacokinetic model used. These models are already loaded onto perfusion devices in the operating room. Patient data such as height, weight, and gender are entered into the device, the target dose is determined by the clinician, and the device calculates the necessary dose for induction and maintenance according to the pharmacokinetic models.
This study was designed as a prospective, randomized, controlled, single-blind (evaluator-blind), three-arm clinical trial comparing the effects of total intravenous anesthesia and inhalation anesthesia, administered with two different target-controlled infusion (TCI) models (Paedfusor and Eleveld), on postoperative awakening agitation in pediatric patients aged 3-10 years with ASA I-II status and scheduled for elective urogenital surgery.
Participants will be randomly assigned to one of three groups: Paedfusor TCI, Eleveld TCI, or sevoflurane anesthesia. Standard monitoring and anesthesia protocols will be applied to all patients. Emergence delirium will be assessed using the Pediatric Anesthesia Emergence Delirium (PAED) scale, and postoperative pain will be evaluated using the FLACC scale.
Secondary outcomes include severity of emergence delirium, association between bispectral index (BIS)-derived alpha band power and ED, time to emergence, postoperative nausea and vomiting, duration of BIS suppression, and the need for additional sedation and analgesia.
This study aims to provide evidence on the optimal anesthetic approach to reduce emergence delirium in pediatric patients and to explore the neurophysiological correlates of ED using BIS monitoring
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Anesthesia will be maintained using propofol with target-controlled infusion based on the Paedfusor pharmacokinetic model.
Drug: propofol ( Paedfusor Model)
Anesthesia will be maintained using propofol with target-controlled infusion based on the Eleveld pharmacokinetic model.
Drug: propofol (Eleveld Model)
Anesthesia will be maintained using sevoflurane inhalational anesthesia.
Drug: Sevofluorane
Propofol will be administered via target-controlled infusion using a Paedfusor model.
Propofol will be administered via target-controlled infusion using the Eleveld model.
Sevoflurane will be administered as an inhalation anesthetic.
Emergence Delirium Assessed by PAED Scale
Postoperative awakening delirium and its severity will be assessed using the Pediatric Anesthesia Awakening Delirium (PAED) scale.
Time frame: Within the first 30 minutes after emergence from anesthesia
Postoperative Pain Assessed by FLACC Scale
Postoperative pain will be assessed using the Face, Legs, Activity, Cry, Consolability (FLACC) scale.
Time frame: Within the first 120 minutes after surgery
Association Between BIS-Derived Alpha Band Power and Emergence Delirium
The relationship between bispectral index (BIS)-derived alpha frequency band power and emergence delirium will be evaluated in patients who develop emergence delirium.
Time frame: Intraoperative period
Time to Emergence
Time from discontinuation of anesthesia to eye opening and response to verbal stimuli.
Time frame: Within the first 120 minutes after surgery
Incidence of Postoperative Nausea and Vomiting
Occurrence of nausea and/or vomiting in the postoperative period.
Time frame: Within 30 minutes after the surgery
Duration of BIS Suppression
Total duration of electroencephalographic suppression periods as detected by BIS monitoring during anesthesia.
Time frame: Intraoperative period
Need for Additional Sedation
Requirement for rescue sedative medication in the postoperative period.
Time frame: 0-30 minutes postoperatively
Need for Additional Analgesia
Requirement for rescue analgesic medication in the postoperative period.
Time frame: 0-30 minutes postoperatively
Plan to share: No — Individual participant data will not be shared due to privacy and ethical considerations, including the protection of personal health information.
No publications or documents are linked to this record.
Started Jan 2026 (actual). Primary completion is estimated for Oct 2027, 20 months after the start.
Of 181 non-industry interventional studies with no phase under Postoperative Nausea and Vomiting, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 26. This study's planned 20 months is above that.
Counting every sponsor, half of 181 studies reached it within 13 months; a quarter within 5 and three quarters within 26.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Propofol
Postoperative Nausea and Vomiting →
Marmara University Pendik Training and Research Hospital